Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Piper Jaffray & Co. Upgrades Career Education (CECO) to Neutral
-
Grand Canyon Education (LOPE) Lowers IPO Price to $16-$18
-
Piper Jaffray Cuts Estimates on LDK Solar (LDK)
-
Piper Jaffray Cuts Price Target on Yingli (YGE) from $26 to $15
-
Notable Analyst Rating Changes 11/06: XTO, HNT, SOV Upgraded; CSIQ, NWS, AMZN, DVN Downgraded
-
Piper Jaffray Downgrades Canadian Solar (CSIQ) to Neutral
-
Piper Jaffray Reiterates a 'Buy' on Myriad Genetics (MYGN), Raises Price Target and Earnings Estimates
-
Piper Jaffray Downgrades Iconix Brand Group (ICON) to Neutral
-
Piper Jaffray Reiterates a 'Buy' on Gilead Sciences (GILD)
-
Piper Jaffray Sees Near-Term Issues For Best Buy (BBY) After Competitors Shakeout, But Long-Term Positive
-
Piper Jaffray Upgrades Neurocrine Biosciences (NBIX) to Neutral
-
Piper Jaffray Downgrades Vocus (VOCS) to Neutral
-
Piper Jaffray Downgrades Parametric Technology (PMTC) to Neutral
-
Piper Jaffray Downgrades Lexicon Pharmaceuticals (LXRX) to Sell
-
Piper Jaffray Downgrades ZymoGenetics (ZGEN) to Neutral
-
Piper Jaffray Downgrades Exelixis (EXEL) to Neutral
-
Piper Jaffray Downgrades ACADIA Pharmaceuticals (ACAD) to Sell
-
Piper Jaffray Downgrades Infinity Pharmaceuticals (INFI) to Neutral
-
Piper Says Baidu's (BIDU) YOUA.com Launch is a Positive
-
Piper Jaffray Upgrades Estee Lauder (EL) to Neutral
-
Piper Jaffray Lowers Estimates and Price Target on Amazon (AMZN), Sees Slow Growth in Q4
-
David Moenning's Daily State of the Markets: 10/22
-
Piper Jaffray Downgrades GATX Corporation (GMT) to Neutral
-
Piper Jaffray Reiterates Neutral Rating on Coach (COH), Raises Price Target to $22
-
Apple (AAPL) Trades Down 5% Ahead of Qtr Results; Stock Down Over 40% Since Last Qtr
-
Piper Jaffray Upgrades Volterra Semiconductor (VLTR) to Buy
-
Munster Says Street Expectations for Apple Are Too Low (AAPL)
-
Gene Munster Said NPD Data Suggests Apple (AAPL) Well-Positioned To Weather The Strom
-
Piper Jaffray & Co. Upgrades TomoTherapy (TOMO) to Buy
-
Piper Jaffray & Co. Downgrades Accuray (ARAY) to Neutral
-
Piper Jaffray Said Google (GOOG) Is Benefiting From the Wal-Mart Effect
-
Piper Jaffray Maintains 'Neutral' Rating on Harley-Davidson (HOG), Drops Price Target and Earnings Estimates
-
Piper Jaffray Upgrades Watsco (WSO) to Buy
-
Notable Analyst Rating Changes 10/16: GSK, ADM, APC, WFC Upgraded; STM, DO, EBAY, MDU Downgraded
-
David Moenning's Daily State of the Markets: 10/16
-
Piper Jaffray Downgrades eBay (EBAY) to Neutral
-
Notable Analyst Rating Changes 10/15: IBM, AAPL, DNA, HD, LOW, LVS Upgraded; DELL, EBAY, SSP Downgraded
-
David Moenning's Daily State of the Markets: 9/15
-
Piper Jaffray (PJC) Reports Q3 Loss of $1.68
-
Piper Jaffray Upgrades Genentech (DNA) to Buy, Valuation Compelling Whether Roche Acquires or Not
-
Piper Jaffray & Co. Upgrades Raven Industries (RAVN) to Neutral
-
Piper Jaffray Maintains a 'Buy' Rating on American Express (AXP), Lowers Earnings Estimates
-
Piper Jaffray Maintains a 'Neutral' Rating on Capital One Financial (COF), Lowers Earnings Estimates
-
Piper Jaffray Reiterates a 'Buy' on athenahealth (ATHN), Adds Stock to Alpha List
-
Piper Jaffray Upgrades Visa (V) to Buy
-
Piper Jaffray Maintains a 'Buy' on Linear Technology (LLTC), Lowers Price Target
-
Piper Jaffray Upgrades THQ Inc. (THQI)
-
Piper Jaffray Upgrades VCA Antech (WOOF) To Buy
-
Piper Jaffray Upgrades GameStop (GME) to Buy; $35 PT
-
Piper Jaffray Upgrades JAKKS Pacific (JAKK) To Buy
